Новые Европейские рекомендации по ведению пациентов с артериальной гипертонией: место сартанов

1. Guidelines for the management of arterial hypertension. J Hypertension 2007; 25: 1105-87.

2. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20 (4): 671-81.

3. Hasford J, Mimran A, Simons WR. A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Human Hypertension 2002; 16 (8): 569-75.

4. Parving HH et al. Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345 (12): 870-8.

5. Lewis EJ et al. Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345 (12): 851-60.